Contraceptive pills induce an improvement in congenital hypoplasminogenemia in two unrelated patients with ligneous conjunctivitis

Summary Severe type I plasminogen deficiency is the underlying cause of ligneous conjunctivitis, a rare disease characterized by wood-like pseudomembranes developing on the ocular and extraocular mucosa. Two unrelated female patients with ligneous conjunctivitis and moderate hypoplasminogenemia are described. Being of fertile age, they were treated with oral contraceptives, which determined a marked increase in plasminogen levels. Moreover, a palpebral pseudomembrane stopped growing in one patient and disappeared completely in the other while on the estroprogestinic treatment. In patient n.2,who also suffered from von Willebrand’s disease, prior Cushing’s disease induced an increase in both von Willebrand factor and plasminogen levels, which dropped after curative hypophysectomy. Genetic plasminogen study showed a 19Lys>Glu mutation in a heterozygous state in the first proposita and in a homozygous state in the second proband. In addition, both index patients were homozygous for a new intron F-14T>G mutation, which was found to reduce the acceptor splicing site prediction score. In conclusion, oral contraceptive therapy may improve plasminogen deficiency and deserves attention as an alternative therapeutic approach in selected cases of ligneous conjunctivitis with low, but not absent, plasminogen synthesis.

[1]  P. Donshik,et al.  Ligneous Conjunctivitis: Biochemical Evidence for Hypofibrinolysis , 2000, Inflammation.

[2]  V. Marzinotto,et al.  Effective treatment of ligneous conjunctivitis with topical plasminogen. , 2002, American journal of ophthalmology.

[3]  U. Ozcelik,et al.  Homozygous and Compound-heterozygous Type I Plasminogen Deficiency Is a Common Cause of Ligneous Conjunctivitis , 2001, Thrombosis and Haemostasis.

[4]  P. Simioni,et al.  State-of-the-Art-Review : Combined Heterozygous Plasminogen Deficiency and Factor V Leiden Defect in the Same Kindred , 2000, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[5]  A. Girolami,et al.  Familial Association of Hypoplasminogenemia and Heterozygous Factor V Deficiency , 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[6]  E. Stiehm,et al.  Compound-heterozygous mutations in the plasminogen gene predispose to the development of ligneous conjunctivitis. , 1999, Blood.

[7]  H. Schwarz,et al.  Human homozygous type I plasminogen deficiency and ligneous conjunctivitis , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[8]  H. Azuma,et al.  Therapy with a purified plasminogen concentrate in an infant with ligneous conjunctivitis and homozygous plasminogen deficiency. , 1998, The New England journal of medicine.

[9]  J. Fontcuberta,et al.  Laboratory Evaluation and Clinical Characteristics of 2,132 Consecutive Unselected Patients with Venous Thromboembolism – Results of the Spanish Multicentric Study on Thrombophilia (EMET*-Study) , 1997, Thrombosis and Haemostasis.

[10]  V. Schuster,et al.  Homozygous mutations in the plasminogen gene of two unrelated girls with ligneous conjunctivitis. , 1997, Blood.

[11]  P. Simioni,et al.  “Pseudo Homozygous” Activated Protein C Resistance due to Double Heterozygous Factor V Defects (Factor V Leiden Mutation and Type I Quantitative Factor V Defect) Associated with Thrombosis: Report of Two Cases Belonging to Two Unrelated Kindreds , 1996, Thrombosis and Haemostasis.

[12]  N. Heimburger,et al.  Familiärer homozygoter und heterozygoter Typ I-Plasminogenmangel , 1996 .

[13]  E. Holland,et al.  Induction of ligneous conjunctivitis by conjunctival surgery. , 1995, American journal of ophthalmology.

[14]  P. Roggenkämper,et al.  Ligneous conjunctivitis. Ten years follow-up. , 1993, Ophthalmic paediatrics and genetics.

[15]  H. Azuma,et al.  Congenital plasminogen deficiency caused by a Ser572 to Pro mutation. , 1993, Blood.

[16]  D. Stefanovic,et al.  [Conjunctivitis lignosa and hydrocephalus (an unusual association of 2 diseases)]. , 1993, Vestnik oftalmologii.

[17]  R. Tait,et al.  Plasminogen Levels in Healthy Volunteers -Influence of Age, Sex, Smoking and Oral Contraceptives , 1992, Thrombosis and Haemostasis.

[18]  T. Shigekiyo,et al.  Danazol Therapy in Hypoplasminogenemia , 1992, Thrombosis and Haemostasis.

[19]  A. Girolami,et al.  Impaired release of tissue plasminogen activator (t‐PA) following DDAVP infusion in von Willebrand's disease with low platelet von Willebrand factor content , 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[20]  Seymour R. Cohen Ligneous Conjunctivitis: An Ophthalmic Disease with Potentially Fatal Tracheobronchial Obstruction , 1990, The Annals of otology, rhinology, and laryngology.

[21]  E. Davie,et al.  Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system. , 1990, The Journal of biological chemistry.

[22]  M. Greaves,et al.  Fibrinolysis during normal human pregnancy: complex inter‐relationships between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clot lysis time , 1988, British journal of haematology.

[23]  B. Risberg,et al.  Determination of plasminogen activator inhibitor in plasma using t-PA and a chromogenic single-point poly-D-lysine stimulated assay. , 1988, Thrombosis research.

[24]  M. Alessi,et al.  Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. , 1988, Blood.

[25]  P. Mannucci,et al.  Congenital plasminogen deficiency associated with venous thromboembolism: therapeutic trial with stanozolol , 1986, British journal of haematology.

[26]  D. Collen,et al.  Assay of Human Tissue-Type Plasminogen Activator (t-PA) with an Enzyme-Linked Immunosorbent Assay (ELISA) Based on Three Murine Monoclonal Antibodies to t-PA , 1985, Thrombosis and Haemostasis.

[27]  M. Boscaro,et al.  Further Studies on the Hypercoagulable State of Patients with Cushing’s Syndrome , 1985, Thrombosis and Haemostasis.

[28]  S. Manabe,et al.  Homozygous protein C deficiency combined with heterozygous dysplasminogenemia found in a 21-year-old thrombophilic male. , 1985, Thrombosis research.

[29]  F. Fabris,et al.  The evaluation of factor VIII antigen by means of a simple slide test. , 1985, American journal of clinical pathology.

[30]  R. Scarpa,et al.  A ‘New’ Congenital Haemorrhagic Condition due to the Presence of an Abnormal Factor X (Factor X Friuli): Study of a Large Kindred , 1970, British journal of haematology.